Immunological Approaches to Tularemia Vaccine Development

Summary

Efforts to develop an effective tularemia vaccine centre on eliciting robust cellular and humoral immunity against the intracellular pathogen Francisella tularensis. Live attenuated strains such as the historical Live Vaccine Strain (LVS) have demonstrated protective efficacy but carry safety concerns and variable potency. Subunit approaches target key antigens, including outer membrane proteins and lipopolysaccharide O-antigen, delivered as recombinant proteins, glycoconjugates or via novel platforms such as viral vectors and bacterial outer membrane vesicles (OMVs). Vector-based vaccines, notably replication-defective adenovirus constructs encoding multiple F. tularensis antigens, have induced Th1-biased T-cell responses and significant protection in animal models. OMVs harness a native antigen repertoire and stimulate innate and adaptive arms, offering a non-viable antigen source. Detailed analyses of human peripheral blood mononuclear cell responses to LVS vaccination have defined memory T-cell subsets and cytokine signatures correlating with protection, informing the rational design and evaluation of next-generation candidates. Together, these immunological strategies aim to achieve durable, safe and broadly protective immunity against pulmonary and systemic tularemia.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Immunological Approaches to Tularemia Vaccine Development publication trend

The graph below shows the total number of articles in immunological approaches to tularemia vaccine development across all publications each year (not limited to Nature Index journals).

Technical terms

Live Vaccine Strain (LVS): An attenuated derivative of F. tularensis used historically to induce immunity in humans and animals.

Peripheral blood mononuclear cells (PBMC): A mixed population of lymphocytes and monocytes used to evaluate human immune responses in vitro.

Th1-biased immune response: A cell-mediated profile characterised by interferon-gamma and related cytokines critical for controlling intracellular pathogens.

Outer membrane vesicles (OMVs): Nanometre-scale blebs released from Gram-negative bacteria containing surface antigens and immunostimulatory components.

Adenovirus-vectored vaccine: A replication-defective viral vector engineered to express target antigens and elicit adaptive immune responses without causing disease.

References

  1. Analyses of human immune responses to Francisella tularensis identify correlates of protection. Frontiers in Immunology (2023).
  2. Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines. Frontiers in Cellular and Infection Microbiology (2023).
  3. Protective potential of outer membrane vesicles derived from a virulent strain of Francisella tularensis. Frontiers in Microbiology (2024).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.